new logo_edited.png
  • Diapin
    • Leadership
  • Product Candidates
    • DT-109
    • DT-678
  • Science
    • Pipeline
    • Publications
    • Resources
  • Disease Focus
    • Arterial Thrombosis
    • Myocardial Infarction
    • Stroke
    • NASH
    • Primary Biliary Cholangitis
    • Familial Partial Lipodystrophy
    • Type II Diabetes
  • News
  • Contact Us
  • Investors
ZZZZZ2338.jpg

Investors

Beijing SL Pharmaceutical Co.

1380510252.jpeg
new logo_edited.png

Ann Arbor, MI

​

Contact: bruce.markham@diapin.com

​

© 2022 Diapin Therapeutics, LLC

  • Diapin
    • Leadership
  • Product Candidates
    • DT-109
    • DT-678
  • Science
    • Pipeline
    • Publications
    • Resources
  • Disease Focus
    • Arterial Thrombosis
    • Myocardial Infarction
    • Stroke
    • NASH
    • Primary Biliary Cholangitis
    • Familial Partial Lipodystrophy
    • Type II Diabetes
  • News
  • Contact Us
  • Investors